News | October 24, 2025
Laurus Labs posts Q2 FY26 consolidated PAT higher at Rs. 195 Cr
Laurus Labs has reported total income of Rs. 1,680.43 crore during the period ended September 30, 2025
Laurus Labs has reported total income of Rs. 1,680.43 crore during the period ended September 30, 2025
The purpose of this investment is to meet the expenditure relating to the civil works to be undertaken for setting up of a manufacturing facility
Laurus Labs has reported total income of Rs. 1,580 crores during the period ended June 30, 2025
Laurus Labs has reported total income of Rs. 1,424.47 crores during the period ended December 31, 2024
Laurus Labs informs that Eight Roads Ventures and F-Prime Capital (Investors) have together invested Rs. 120 crores in Laurus Bio
He did Master’s of Pharmacy (Pharmaceutical Technology, Formulations) from National Institute of Pharmaceutical Education and Research, Mohali and Bachelor of Pharmacy from Osmania University
Laurus Labs has reported total income of Rs. 1,228.30 crores during the period ended September 30, 2024
Laurus Labs has reported total income of Rs. 1,197.42 crores during the period ended June 30, 2024
Laurus Labs receives EIR from USFDA for API facilities
KRKA holds 51% and Laurus Labs holds 49% shareholding
Subscribe To Our Newsletter & Stay Updated
